India's Council for Scientific and Industrial Research (CSIR) has launched a scientifically validated ayurvedic drug (BGR-34) for type II diabetes. The drug Blood Glucose Regulator-34 (BGR-34) was jointly developed by two research units of CSIR- the National Botanical Research Institute (NBRI) and the Central Institute for Medicinal and Aromatic Plants (CIMAP).
The drug is made of extracts from six herbs including daruharidra (berberis aristata), giloy (tinospora cordifolia), vijayasar (pterocarpus marsupium), gudmar (gymnema sylvestre), majeeth (rubia cordifoila) and methika (trigonella foenumgraecum). Dr A K S Rawat, senior principal scientist, CSIRNBRI said India is home to around 60 million diabetics. "BGR-34 works by controlling blood sugar and limiting the harmful effects of other drugs," he added.
